OrthoPediatrics (NASDAQ:KIDS) CEO Sells $336,978.75 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) CEO David Bailey sold 19,535 shares of the business’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $17.25, for a total value of $336,978.75. Following the completion of the transaction, the chief executive officer directly owned 298,020 shares of the company’s stock, valued at approximately $5,140,845. This trade represents a 6.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

OrthoPediatrics Price Performance

KIDS opened at $16.54 on Friday. The company’s 50-day simple moving average is $17.63 and its two-hundred day simple moving average is $17.92. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.65 and a current ratio of 5.55. The stock has a market capitalization of $418.13 million, a P/E ratio of -9.79 and a beta of 1.07. OrthoPediatrics Corp. has a 52-week low of $15.28 and a 52-week high of $26.40.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.26) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.11. OrthoPediatrics had a negative net margin of 16.77% and a negative return on equity of 6.70%. The firm had revenue of $61.61 million during the quarter, compared to analyst estimates of $61.27 million. As a group, analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Institutional Investors Weigh In On OrthoPediatrics

Hedge funds and other institutional investors have recently modified their holdings of the stock. Russell Investments Group Ltd. lifted its position in OrthoPediatrics by 433.1% during the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock valued at $26,000 after purchasing an additional 1,139 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its position in OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock worth $46,000 after buying an additional 2,561 shares in the last quarter. Caption Management LLC purchased a new stake in OrthoPediatrics in the third quarter worth about $54,000. BNP Paribas Financial Markets raised its stake in shares of OrthoPediatrics by 60.2% in the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares during the period. Finally, State of Wyoming raised its stake in shares of OrthoPediatrics by 189.7% in the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock worth $121,000 after buying an additional 4,467 shares during the period. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have commented on KIDS. BTIG Research lifted their target price on shares of OrthoPediatrics from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, February 27th. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a research note on Thursday, January 22nd. Truist Financial lifted their price objective on OrthoPediatrics from $19.00 to $20.00 and gave the stock a “hold” rating in a report on Monday, March 2nd. TD Cowen upgraded OrthoPediatrics to a “strong-buy” rating in a research report on Tuesday, January 27th. Finally, Needham & Company LLC increased their target price on OrthoPediatrics from $26.00 to $30.00 and gave the company a “buy” rating in a report on Friday, February 27th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $24.67.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.